Table 2.
| compound | MRSA-1707 MIC | HeLa cytotox. (IC50) | J774 MΦ cytotox. (IC50) | Hep G2 cytotox. (IC50) | HEK-293 cytotox. (IC50) |
|---|---|---|---|---|---|
| 3 | 1.56 | >100 | >100 | >100 | |
| 21 | 0.30 | >100 | >200 | >200 | |
| 24 | 0.30 | >100 | >200 | >200 | |
| 27 | 0.78 | 100 | |||
| 28 | 0.15 | >100 | >200 | >200 | |
| 29 | 0.08 | >100 | >200 | >200 | 18.3 ± 5.8 |
| 30 | 0.08 | >200 | >200 | ||
| 31 | 0.59 | >200 | >200 | ||
| 32 | 0.15 | >100 | >200 | >200 | |
| 33 | 0.15 | >25 | >200 | >200 | |
| 34 | 0.59 | >100 | >200 | >200 | |
| 35 | 0.30 | 100 | >200 | >200 | |
| 45 | 0.30 | >100 | >200 |
All results are reported in micromolar (μM) concentrations.
Assay information: HeLa cytotoxicity (24 h, LDH release assay), J774 MΦ cytotoxicity (24 h, Alamar Blue assay), HepG2 cytotoxicity (24 h, Alamar Blue assay), HEK-293 cytotoxicity (72 h, MTT assay).
Note: All experimental results are reported from a minimum of three independent cytotoxicity experiments.